🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🚨New Podcast Alert🚨 In episode 108, the rest of the PharmExec editorial staff join PharmExecElaine Quilici and Miranda Schmalfuhs to give more insight into the profiles they've written about the eleven members of our 2022 Emerging Pharma Leaders 🎙️ow.ly/OIOK50J6iQq #pharma

🚨New Podcast Alert🚨 David Sanders, VP of government affairs & policy, Coherus Oncology , speaks about the firm’s goal of expanding #patientaccess to cost-effective medication, his role with Securing America's Medicines and Supply, and much more! 🎙️ow.ly/HrXb50J7ppH #pharma #lifesciences #supplychain

🚨Our June issue is LIVE🚨 The impact of war on drug #supplychain ▪️What makes #hub programs successful?▪️Counting down to 2023 #DSCSA #compliance ▪️and so much more right here➡️pharmaceuticalcommerce.com/view/pharmaceu… #pharma #lifesciences #pharmaceutical #manufacturing

🚨Our July issue is LIVE🚨 An insightful discussion with OtsukaUS' Christine Sakdalan🔷the changing role of #biopharma CFOs🔷Rethinking commission-based deals with independent contractors🔷and so much more waiting right here➡️ow.ly/ra7450JSKKN #pharma #lifesciences

🔸Congratulations to our 2023 Emerging Pharma Leaders🔸 Natasha Hernday of @SeagenGlobal Simon Holland of Organon Biosimilars Justin To of BridgeBio Pharma Frank Watanabe of Arcutis Biotherapeutics Hanadie Yousef of Juvena Therapeutics Read their profiles here: pharmexec.com/journals/pharm…

🔸Read about 2023 #EmergingPharmaLeader Justin To, Chief Operating Officer, Skeletal Dysplasias and Gene Therapy, BridgeBio Pharma ! 🔸 The recipe for cross-functional collaboration in #drugdevelopment🖋️Mike Hollan ➡️pharmexec.com/view/justin-to… #GeneTherapy #pharmaceutical